19 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial)Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, agnosia, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, nervous system disorder, perceptual disorders, stomach disorderRecruitingNot applicable2026-10-01NCT07714980
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)Acute Ischemic Stroke, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral infarction, cerebrovascular disorder, ischemic disease, ischemic stroke, nervous system disorder, stroke disorder, vascular disorderRecruitingPhase 32026-09-24NCT06548971
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorderActive, not recruitingPhase 32026-09-24NCT06018337
A Study of ATG-022 Compared With Investigator's Choice of Treatment in Claudin 18.2-Positive Advanced Gastric or Gastroesophageal Junction AdenocarcinomaAdvanced Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruitingPhase 32026-08-31NCT07795346
Pregnancy Salt Substitution Trial for Hypertensive Disorders of Pregnancy Prevention (PREG-Salt)Hypertensive Disorders of PregnancyRecruitingNot applicable2026-08-28NCT07294807
A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorderActive, not recruitingPhase 32026-08-11NCT06680921
Phase II Trial of Iparomlimab/Tuvonralimab (QL1706) + XELOX in HER2-Negative, Low PD-L1 G/GEJ AdenocarcinomaHER2 Negative; Low PD-L1 Expressing; Unresectable or Metastatic Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingPhase 22026-05-07NCT06932068
Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral HemorrhageHemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cyclopia sequence, intracerebral hemorrhage, nervous system disorder, vascular disorderRecruitingPhase 32026-04-23NCT07338175
Ongericimab Injection Reducing Recurrence of Ischemic Strokebrain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorderNot yet recruitingPhase 32026-04-16NCT07242599
A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast CancerHER2-positive Breast CancerRecruitingPhase 32026-03-27NCT07043725
Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid NodulesHead and Neck Neoplasms, Neoplasms by Site, Thyroid Nodule, endocrine system disorder, malignant endocrine neoplasm, neoplasm, thyroid gland disorder, thyroid tumorRecruitingPhase 42026-03-24NCT06423235
A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinomaNot yet recruitingPhase 42026-03-20NCT07485920
Osteoporotic Vertebral Compression Fracture Cohort StudyCohort Study; OVCF DatabaseNot yet recruitingNot stated2026-01-09NCT07321795
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patientsacute coronary syndrome, cardiovascular disorder, heart disorder, myocardial ischemia, vascular disorderRecruitingPhase 42025-09-16NCT04728516
Mobile Applet for Weight Management in Obese Heart Failure PatientsBody Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, cardiovascular disorder, heart disorder, heart failure, nutritional disorder, obesity disorder, overnutritionRecruitingNot applicable2025-06-27NCT06455878
Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell LymphomaB-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmRecruitingPhase 22025-03-24NCT06854445
Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Capsule and Chemotherapy in the Treatment of Immunoresistant Advanced Non-small Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 22024-09-19NCT06141226
D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy FailureNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 32024-04-26NCT06300177
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS Systemcardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorderNot yet recruitingNot applicable2021-08-06NCT04995159